Is Seroxat the most complained about antidepressant?

#links


Sunday, October 26, 2008
Obesity drug withdrawn over depression link
Source: The Guardian

Sales and prescriptions of a weight-loss drug were suspended yesterday after European health authorities said the benefits no longer outweighed the risks.

The European Medicines Agency said obese people taking Acomplia were roughly twice as likely to develop psychiatric disorders, such as depression, anxiety and aggression, than those taking a placebo. US authorities have refused to allow Acomplia to be marketed in America.

The Medicines and Healthcare products Regulatory Agency (MHRA), which oversees drugs in the UK, said that as a result of the ruling, healthcare professionals would be told not to give any new prescriptions for Acomplia. Patients taking the drug have been told to consult their doctor.





FULL STORY





Yet Seroxat and other SSRi's remain on the market despite the thousands of adverse reactions reported to the MHRA.





This file from the MHRA website recieved no publicity, they released it on the 13th October 2008 - SSRI anti-depressants - withdrawal and side effects (08/319)





There have been 1,425 'reported' reactions of Seroxat, only 156 of these have been reported by patients under the age of 24 which leaves 1,370 reports from patients over the age of 24. Yet the MHRA have banned the use of Seroxat in patients where there are less adverse reactions. How absurd is this?





Remember these are just the 'reported' reactions to Seroxat, there are literally thousands of others that haven't been reported to the MHRA. One only has to visit Paxil Progress to see how many people are suffering at the hands of Seroxat.

I've been accused by members of a mental health forum for concentrating too much on Seroxat, the latest release by the MHRA shows why I write what I do about it. These same people accuse me of having a vested interest in Seroxat because I am part of the Seroxat litigation here in the UK. This blog was created long before I knew I was part of the litigation.

Other 'reports' of SSRi withdrawal from the recent MHRA file are:

Citalopram [Cipramil] - TOTAL 170
Duloxetine [Cymbalta] - TOTAL 55
Escitalopram [Cipralex] - TOTAL 53
Fluvoxamine [Luvox] - TOTAL 161
Fluoxetine [Prozac] - TOTAL 680
Sertraline [Zoloft] - TOTAL 162
Venlafaxine [Efexor] - TOTAL 318

I am 100% certain that these figures for all SSRi drugs are vastly underplayed. However, it seems that Seroxat with 1,425 'reported' adverse reactions more than doubles that of any other SSRi on the market. And people wonder why myself and others create awareness about the dangers of it!

Fid




Posted by Fiddy at 4:41 AM 0 comments Links to this post
Labels: GSK - Brushed Under The Carpet, MHRA Correspondence,